Literature DB >> 5781092

Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.

W A Hook, M A Chirigos, S P Chan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5781092

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Lymphocytic choriomeningitis of the mouse. IV. Depression of the allograft reaction.

Authors:  F Lehmann-Grube; I Niemeyer; J Löhler
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

2.  Effect of histone on oncogenic properties of Moloney's murine sarcoma virus.

Authors:  I G Balandin; A M Amchenkova; V D Koltsov; L L Krimskaja; A A Lushnikov
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  [Virus infected lymphoblasts acting as antigen for the production of heterologous antilymphocyte sera].

Authors:  G Bandlow; F Kieling; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

4.  Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans.

Authors:  D M Adamson; G C Cozad
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

5.  Submandibular gland-conditioned medium enhancement of bone marrow colony-forming cells in tumor-bearing murine recipients.

Authors:  D F Gruber; G D Ledney
Journal:  Experientia       Date:  1983-01-15

6.  Immunosuppression by murine sarcoma virus (Moloney).

Authors:  S P Chan; W A Hook; W Turner; M A Chirigos
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

7.  Increased Incidence of Lymphoma in C3H/HeJ Adult Mice Injected with Gross Virus and Antithymocytic Serum.

Authors:  D L Vredevoe; E F Hays
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

8.  Prevention of murine sarcoma virus oncogenesis in offspring of immunized female mice.

Authors:  L Chieco-Bianchi; D Collavo; G Biasi; A Colombatti
Journal:  Br J Cancer       Date:  1973-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.